1. What is the size of the Japan ophthalmic viscoelastic devices market?
The Japan OVD market was valued at approximately $0.18 billion in 2023 and is projected to reach $0.30 billion by 2033, growing at a CAGR of 5.2%.
+1 2315155523
Market Lens IQ is a global market intelligence and strategic consulting firm delivering advanced syndicated research reports, customized industry analysis, competitive intelligence, and data-driven advisory solutions to organizations across international markets. With a strong commitment to analytical excellence and innovation, Market Lens IQ empowers enterprises, investors, consultants, and decision-makers with actionable insights that drive strategic growth, operational efficiency, and long-term business transformation in highly competitive industries. The company serves a broad spectrum of industry verticals, including Life Sciences, Consumer Goods, Semiconductor and Electronics, Materials and Chemicals, Construction and Manufacturing, Food and Beverages, Energy and Power, Automotive and Transportation, ICT and Media, Aerospace and Defense, and BFSI (Banking, Financial Services, and Insurance). By combining deep domain expertise with advanced analytics, Market Lens IQ delivers comprehensive market assessments, technology trend analysis, investment intelligence, supply chain insights, pricing analysis, customer behavior studies, and future market forecasts tailored to evolving business requirements.
At the core of Market Lens IQ’s capabilities lies a robust 360-degree research methodology integrating primary research, secondary research, expert interviews, data triangulation, AI- powered analytics, and real-time market monitoring. Our research framework ensures the highest standards of data accuracy, reliability, and strategic relevance by leveraging industry databases, corporate filings, government publications, trade journals, regulatory frameworks, white papers, investor presentations, and global economic indicators. The company specializes in identifying emerging market opportunities, disruptive technologies, innovation ecosystems, competitive benchmarking, regulatory shifts, and high-growth investment segments across global industries. Driven by a client-centric approach, Market Lens IQ collaborates with startups, SMEs, multinational enterprises, private equity firms, institutional investors, and Fortune 500 companies to deliver high-value business intelligence solutions that support informed decision-making and sustainable competitive advantage. Through continuous innovation, digital intelligence capabilities, and industry-focused expertise, Market Lens IQ has established itself as a trusted strategic partner in the global market research and consulting landscape, helping organizations navigate market complexities and capitalize on transformative growth opportunities.
Research Analyst


The Japan ophthalmic viscoelastic devices (OVD) market represents one of the most technically sophisticated and clinically mature segments of the country's medical device landscape. Our proprietary primary research estimates the market at $0.18 billion in 2023, with a projected trajectory to $0.30 billion by 2033, registering a CAGR of 5.2%. This growth is anchored in Japan's demographic reality: over 10% of the population is aged 80 or above, and the prevalence of age-related ocular pathologies continues to rise.
OVDs are indispensable in anterior and posterior segment surgery, primarily for maintaining the anterior chamber, protecting the corneal endothelium, and facilitating intraocular lens (IOL) implantation. Japan's surgical volume remains among the highest per capita globally, with approximately 249,176 ophthalmological surgeries performed in 2021, of which cataract procedures accounted for 44.6%. This procedure base provides a stable, recurring demand floor for OVD consumption.
The Japan OVD market is segmented by product, application, and end user. Our analysis reveals clear leadership positions and emerging growth pockets.
| Segment | Sub-segment | 2023 Share Position | Growth Outlook |
|---|---|---|---|
| By Product | Cohesive OVD | Dominant | Moderate |
| Dispersive OVD | Smaller | Fastest CAGR | |
| By Application | Cataract Surgery | Dominant (>60%) | Moderate |
| Glaucoma Surgery | Emerging | Fastest CAGR | |
| Corneal Transplant | Niche | Stable | |
| Vitreoretinal Surgery | Niche | Stable | |
| By End User | Hospitals | Dominant | Moderate |
| Ophthalmic Clinics | Growing | Fastest CAGR | |
| Others (ASC, academic) | Niche | Stable |
Cohesive OVDs dominate due to their superior chamber maintenance and ease of removal, particularly in standard cataract procedures. However, dispersive OVDs are gaining traction in complex cases requiring endothelial protection, driving their faster growth. Similarly, while cataract surgery remains the volume anchor, glaucoma surgery is expanding as minimally invasive glaucoma surgery (MIGS) adoption increases.
The Japan OVD market is characterized by a mix of global ophthalmic leaders and specialized domestic manufacturers. Our primary research identifies the following key players actively shaping the competitive dynamics:
Competitive strategies center on product differentiation through clinical evidence, surgeon education, and bundling with IOLs or surgical equipment. Price competition is intense in commodity cohesive OVDs, while premium dispersive and combination products command higher margins.
Japan is a net importer of advanced OVD formulations, particularly dispersive and combination products from global manufacturers based in the US and Europe. However, domestic production is significant, with companies like Seikagaku and Santen manufacturing hyaluronic acid-based OVDs locally. The supply chain is well-developed, supported by Japan's robust logistics and regulatory infrastructure.
Key supply chain considerations include:
Japan's OVD demand is geographically concentrated in urban centers, mirroring population density and healthcare infrastructure. The Kanto region (Tokyo, Yokohama, etc.) accounts for the largest share of ophthalmic surgeries and OVD consumption, followed by Kansai (Osaka, Kyoto) and Chubu (Nagoya). Rural regions, while having a higher proportion of elderly residents, face challenges in accessing advanced surgical care, leading to lower OVD utilization per capita.
Several white-space opportunities emerge from our analysis:
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 5.2% from 2020-2034 |
| Segmentation |
|
Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.
| Stakeholder Role | Interview Share (%) |
|---|---|
| Ophthalmic Surgeons | 35% |
| Hospital Procurement Managers | 25% |
| Regulatory Affairs Specialists | 20% |
| Product Development Leads | 20% |
| Company Type | Representation (%) |
|---|---|
| OVD Manufacturers (Domestic) | 30% |
| OVD Manufacturers (International) | 25% |
| Ophthalmic Surgical Distributors | 20% |
| Hospital Procurement Officers | 15% |
| Regulatory Consultants | 10% |
The Japan OVD market was valued at approximately $0.18 billion in 2023 and is projected to reach $0.30 billion by 2033, growing at a CAGR of 5.2%.
Cohesive OVDs dominate the market due to their superior chamber maintenance and ease of use in cataract surgery, though dispersive OVDs are growing faster.
Key drivers include Japan's aging population, high cataract surgery volume, technological advancements in OVD formulations, and government reimbursement support.
Major players include Alcon, Bausch + Lomb, Johnson & Johnson Vision, Carl Zeiss Meditec, Santen Pharmaceutical, Hoya Corporation, and Seikagaku Corporation.
Glaucoma surgery is the fastest-growing application segment, driven by the rising prevalence of glaucoma and adoption of minimally invasive surgical techniques.